A glucose-raising hormone in a glucose-lowering compound

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Glucagon raises blood glucose, so including glucagon receptor activity in a compound intended to improve glycaemia appears contradictory. The resolution, set out in the discovery paper and borne out in the phase 2 glycaemic data, is that incretin activity in the same molecule offsets the glucose effect while glucagon's effects on energy expenditure and the liver persist.

The paradox stated

Glucagon is the body's principal signal to release stored glucose. An agent that activates its receptor should, on that effect alone, worsen glycaemic control. Earlier interest in glucagon for weight was tempered by exactly this.

Yet glucagon also increases energy expenditure and lipid oxidation, which are desirable in the same context. The two effects pull in opposite directions on the two outcomes.

How the design addresses it

Pairing glucagon activity with potent incretin activity means insulin secretion is enhanced in a glucose-dependent way at the same time, countering the glucose rise. Whether the balance works is empirical, and in the phase 2 trials glycated haemoglobin fell rather than rose.

That result is the resolution of the paradox for this molecule. It is not a general proof that glucagon agonism is safe in any combination.

What remains inferred

Energy expenditure was increased by the glucagon component in rodent studies. It was not directly measured in the phase 2 human trials, so its contribution to the weight results in people is inferred from the design and the animal data rather than demonstrated.

That gap is routinely closed in secondary summaries and should not be.

Supply

Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Retatrutide Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

The paradox stated?

Glucagon is the body's principal signal to release stored glucose. An agent that activates its receptor should, on that effect alone, worsen glycaemic control. Earlier interest in glucagon for weight was tempered by exactly this.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Retatrutide Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.